Quantcast

Latest nausea Stories

2009-04-21 10:38:00

SARASOTA, Fla., April 21 /PRNewswire/ -- WellSpring Pharmaceutical Corporation announced earlier today that Emetrol (R), its liquid anti-nausea brand is now the leading product in its category. Based on trailing 52 weeks sales (ending 1/14/09) Emetrol(R) garnered 51.7 % of the brand category displacing all others including private label. The most recent IRI reports indicate that Emetrol (R) sales are up 24% over last year reflecting the fact that it is recommended by name by OB/GYN's,...

2009-04-15 22:51:20

U.S. doctors say acupressure wristbands can ease nausea in patients receiving radiation treatment. Previously, the researchers attributed nausea reduction with wristbands to the placebo effect -- having an outcome in the body the mind expected. We know the placebo effect exists, the problem is that we don't know how to measure it very well, corresponding author Joseph Roscoe of the University of Rochester Medical Center in New York said in a statement. In this study we attempted to...

2009-04-09 07:14:47

Cancer patients who wore acupressure wristbands had much less nausea while receiving radiation treatment, making the bands a safe, low-cost addition to anti-nausea medication, according to a study published in the Journal of Pain and Symptom Management by University of Rochester Medical Center researchers.Previous research has suggested that the placebo effect "“ essentially, an outcome related to your body that you expect to happen "“ might be why elastic wristbands reduce...

2009-03-20 06:00:00

ZURICH, Switzerland, March 20 /PRNewswire/ -- A new, innovative study shows that a single dose of palonosetron, the second generation 5-HT3 antagonist, plus dexamethasone not only prevents chemotherapy-induced nausea and vomiting (CINV), but also allows adequate caloric intake in oncology patients. Data presented today at the ESMO Symposium on Cancer and Nutrition in Zurich, Switzerland New data presented today at the ESMO (European Society of Medical Oncology) Symposium on Cancer...

2009-02-12 15:24:00

CHARLESTON, S.C., Feb. 12 /PRNewswire/ -- Charleston Laboratories, Inc, an emerging specialty pharmaceutical company dedicated to reducing opioid-induced nausea and vomiting (OINV) in opioid pharmaceuticals, announced preliminary findings from its development and testing of an Opioid Symptoms Questionnaire, or OSQ, which will be used in Charleston's clinical trials. "This pilot methodology study was designed to test the feasibility and reliability of the OSQ," reported Dr. Bernard...

2009-02-02 15:50:00

Charleston Completes Preliminary Research on Nausea-Prone Questionnaire (NPQ) CHARLESTON, S.C., Feb. 2 /PRNewswire/ -- Charleston Laboratories, Inc., an emerging specialty pharmaceutical company dedicated to reducing opioid induced nausea and vomiting (OINV) in opioid pharmaceuticals, announced today the completion of its testing of a Nausea-Prone Questionnaire, or NPQ, to be used in its Phase III clinical trials. "An important purpose of this randomized controlled trial was to test and...

2009-01-15 14:58:00

HARRISBURG, Pa., Jan. 15 /PRNewswire-USNewswire/ -- Outbreaks of viral gastroenteritis, or "stomach flu," are sharply on the rise in Pennsylvania, prompting the Department of Health to offer tips to help prevent the spread of the highly contagious norovirus infection -- a common cause of the illness. "Norovirus infection is very common this time of year and spreads easily," said state Acting Health Secretary Everette James. "If you have symptoms such as vomiting and diarrhea, you should try...

2008-12-12 11:12:32

After a tonsillectomy, it seems patients are caught in a Catch-22. New research shows a commonly used steroid to reduce nausea and vomiting is associated with an increased risk of postoperative bleeding. About 186,000 tonsillectomies are performed each year in the United States, making the outpatient procedure one of the most frequently performed surgical procedures in children. Dexamethasone injected after the start of anesthesia can reduce the nausea and vomiting often experienced after...

2008-12-04 07:00:00

WALTHAM, Mass., Dec. 4 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that Eisai/Helsinn Healthcare's Aloxi's marketing message ("Better in acute, better in delayed") is rated the most influential by oncologists in the chemotherapy-induced nausea and vomiting drug market. Oncologists accurately identified Aloxi's messages with the brand, highlighting the strength of the Aloxi messaging...

2008-11-05 06:00:06

A.P. Pharma, Inc. (NASDAQ: APPA), a specialty pharmaceutical company, today reported financial results for its third quarter ended September 30, 2008. The company also announced additional positive clinical data for its lead product, APF530, which has successfully completed a Phase 3 trial for the treatment of chemotherapy-induced nausea and vomiting (CINV). In addition, in order to better focus the company's resources on APF530 in light of current conditions in the capital markets, A.P....


Word of the Day
baudekin
  • A rich embroidered or brocaded silk fabric woven originally with a warp of gold thread.
'Baudekin' seems to be an alternative form of 'baldachin,' from the Italian 'Baldacco,' Baghdad, the city where the material was made.
Related